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Summary
Human Serum Albumin (HSA) accounts for 60% of the total protein in blood serum and it
is the most widely used intravenous protein in a number of human therapies. HSA, however,
is currently extracted only from blood because of a lack of commercially feasible
recombinant expression systems. HSA is highly susceptible to proteolytic degradation in
recombinant systems and is expensive to purify. Expression of HSA in transgenic chloroplasts
using Shine-Dalgarno sequence (SD), which usually facilitates hyper-expression of
transgenes, resulted only in 0.02% HSA in total protein (tp). Modification of HSA regulatory
sequences using chloroplast untranslated regions (UTRs) resulted in hyper-expression of HSA
(up to 11.1% tp), compensating for excessive proteolytic degradation. This is the highest
expression of a pharmaceutical protein in transgenic plants and 500-fold greater than
previous reports on HSA expression in transgenic leaves. Electron micrographs of
immunogold labelled transgenic chloroplasts revealed HSA inclusion bodies, which provided
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foreign proteins that are highly susceptible to proteolytic degradation and provide
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advantages in purification, when inclusion bodies are formed.

Introduction
Availability of recombinant human proteins has revolutionized
the use of therapeutically valuable proteins in clinical medicine.
Plants offer a suitable alternative to microbial or animal expression of biopharmaceutical proteins because of their inexpensive
production costs and absence of human pathogens. However,
there are some limitations. In particular, expression of human
proteins in nuclear transgenic plants has been disappointingly
low, e.g. human serum albumin 0.02% of total soluble protein (tsp), human Interferon-β 0.000017% of fresh weight,
human epidermal growth factor 0.001% of tsp and erythropoietin 0.0026% of tsp (Daniell et al., 2001d). Therefore, it
is important to increase levels of expression in order to exploit
plant production of pharmacologically important proteins.
© 2003 Blackwell Publishing Ltd

As an alternative to nuclear expression, the chloroplast
transgenic approach has been developed as an effective tool
for the expression of biopharmaceutical proteins in plants
(Daniell and Dhingra, 2002; Daniell et al., 2001a,b; DeGray
et al., 2001; Guda et al., 2000; Staub et al., 2000). After the
first demonstration of a protein based polymer expression
with varied medical applications (Guda et al., 2000), transgenic chloroplasts have been shown to express very small
antimicrobial peptides without fusion proteins (DeGray et al.,
2001), assemble functional oligomers with disulphide bonds
of the cholera toxin β-subunit (Daniell et al., 2001b), and
express a monoclonal antibody with coordinated expression
and assembly of heavy and light chain with proper folding
and formation of disulphide bridges (Daniell et al., 2001a),
suggesting that adequate redox environment or required
71
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chaperonins are present within chloroplasts. Expression of
functional human somatotropin in transgenic tobacco chloroplasts established that chloroplasts are capable of proper
folding of human proteins with disulphide bonds (Staub
et al., 2000). The ability to express multiple genes in a single
transformation event (Daniell and Dhingra, 2002; De Cosa
et al., 2001), accumulation of exceptionally large quantities
of foreign proteins (De Cosa et al., 2001), successful engineering of tomato chromoplasts for high level transgene
expression in fruits (Ruf et al., 2001), coupled to hyperexpression of vaccine antigens (Daniell et al., 2001b), and the
use of plant derived antibiotic free selectable markers (Daniell
et al., 2001c), augur well for oral delivery of edible vaccines
and biopharmaceuticals that are currently beyond the reach
of those who need them most. In addition, chloroplast

highly susceptible to proteolytic degradation. It is known that
traditional purification of biopharmaceuticals using columns
accounts for 30% of the production cost and 70% of the
set up cost (Petrides et al., 1995). Proteolytic degradation
is another serious concern for industrial bioprocessing. The
increasing production of proteins in heterologous hosts
through the use of recombinant DNA technology has brought
this problem into focus; heterologous proteins appear to
be more prone to proteolysis (Enfors, 1992). Recombinant
proteins are often regarded by a cell as foreign and therefore
degraded much faster than most endogenous proteins
(Rozkov et al., 2000). Proteolytic stability of recombinant
proteins is a significant factor influencing the final yield.
This study attempts to develop a more efficient method of
recombinant HSA production, which may be used as a model

genetic engineering is an environmentally friendly approach,
offering containment of transgenes and a solution to gene
silencing and position effect encountered in nuclear transgenic plants (Bogorad, 2000; Daniell and Dhingra, 2002;
Daniell et al., 2002; Daniell, 2002).
HSA is the most widely used intravenous protein and is prescribed in multigram quantities to replace blood volume in
trauma and in various other clinical situations (Peters, 1995).
HSA is a monomeric globular prepro-protein whose mature
form consists of a single polypeptide chain of 585 amino
acids (66.5 kDa with 17 disulphide bonds). The annual world
need exceeds 500 tons, representing a market value of more
than $1.5 billion. To date, albumin has been produced primarily by the fractionation of blood serum. Lack of glycosylation
facilitates production of functional HSA in prokaryotic
systems. Although the HSA gene and cDNA have been
expressed in a wide variety of microbial systems, including
E. coli (Latta et al., 1987), Bacillus subtilis (Saunders et al.,

system to enrich or purify biopharmaceutical proteins from
transgenic plants, which are highly susceptible to proteolytic
degradation.

1987), Saccharomyces cerevisiae (Quirk et al., 1989), Kluyveromyces (Fleer et al., 1991) or Pichia pastoris (Ohtani et al.,
1998), no system is yet commercially feasible. Sijmons et al.
(1990) made the first reported attempt to express HSA in
transgenic plants, but very low expression levels were
attained (0.02% tsp). HSA could not be detected if expressed
in the cytoplasm, suggesting that the protein is not stable in
this compartment, due to high susceptibility to proteolytic
degradation. A 10-fold increase in HSA accumulation has
been reported recently by nuclear transformation of potato
plants and targeting the HSA to the tuber apoplast (Farran
et al., 2002). Estimates by industry, however, suggest that the
cost-effective yield for pharmaceutical production is 0.1 mg
of HSA per gram of fresh weight (Farran et al., 2002).
In addition, good recombinant systems are still not available for many human proteins that are expensive to purify or

have been shown for different proteins using this 5′ sequence
(Daniell et al., 2001b; DeGray et al., 2001; Kota et al., 1999).
In the pLDApsbAHSA vector (Figure 1a), the 204 bp tobacco
chloroplast DNA fragment containing the promoter and the
psbA 5′UTR was inserted immediately upstream of the HSA
coding sequence and downstream of the aadA gene. It is
well known that foreign genes under the control of the
psbA promoter and untranslated region are expressed at
very high levels (Daniell et al., 1990). This enhancement of
translation may be due to elements in the 5′UTR (Eibl et al.,
1999). Vectors were bombarded into tobacco leaves as
described previously (Daniell, 1997) and, after 5 weeks,
several primary shoots appeared from each bombarded leaf
as a result of independent transformation events. Putative
transformed shoots were identified by growth on 500 µg/mL
of spectinomycin.

Results and discussion
Two chloroplast transformation vectors were designed with
different 5′ regulatory sequences to direct HSA expression
and maximize protein accumulation in transgenic chloroplasts. Basic pLD vector, developed in this laboratory for chloroplast transformation, was used (Daniell et al., 1998; Daniell
et al., 2001b; De Cosa et al., 2001; Guda et al., 2000; Kota
et al., 1999). In the plasmid pLDAsdHSA (Figure 1a), the aadA
gene, which confers spectinomycin resistance, and the HSA
gene are expressed as a polycistron from the plastid Prrn
promoter. The Shine-Dalgarno (SD) consensus sequence
GGAGG was placed upstream of both genes. High levels
of foreign protein expression in chloroplasts (3–21% of tsp)

© Blackwell Publishing Ltd, Plant Biotechnology Journal (2003), 1, 71–79
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homoplasmic T0 lines and confirm stable maintenance of
integrated transgenes in the T1 generation (Figure 1b–d). The
flanking region probe (P1) identified a 7.45 kb fragment in
the untransformed control plant, as expected (Figure 1c). In the
chloroplast transgenic lines, only transformed genome copies
are observed as evidenced by the 10.5 and 10.7 kb hybridizing
fragments for pLDAsdHSA and pLDApsbAHSA transgenic lines,
respectively. To confirm that the 10.5 and 10.7 kb fragments
contained the HSA gene, the same blot was reprobed with
the HSA P2 probe. As expected, hybridization was detected
only in the chloroplast transgenic lines (Figure 1d). Absence
of other hybridizing fragments eliminates nuclear and
chloroplast integration events in the same transgenic line.
HSA quantities in transgenic tobacco chloroplasts were
determined by ELISA. More than a 360-fold difference in HSA

Figure 1 Integration of transgene cassettes into the chloroplast genome
and study of homoplasmy. (a) Regions for homologous recombination are
underlined in the native chloroplast genome. HSA is driven in all cassettes
by the Prrn promoter upstream of the aadA gene for spectinomycin
resistance with additional promoters and control elements as described
in the text. Arrows within boxes show the direction of transcription.
Numbers to the right indicate the predicted hybridizing fragments when
total DNA digested with BamHI is probed with probe P1. (b) The 0.81 kb
fragment (P1) flanking the cassette and 0.75 kb fragment containing
HSA coding region (P2) were used as probes for the Southern blot
analysis. (c, d) Southern blot analysis. 1: untransformed DNA; DNA from
plants transformed with: 2,3: pLDAsdHSA; 4,5: pLDApsbAHSA. Plants for
the first (T0) and second (T1) generation were analysed. 2,4: T0 generation.
3,5: T1 generation. Blots were probed with P1 (c) and P2 (d). AadA:
aminoglycoside 3′-adenylyl transferase; kb: kilobases; P: promoter; Prrn:
16SrRNA promoter; SD: Shine-Dalgarno.

Integration of the foreign gene cassettes into the chloroplast genome was confirmed by PCR screening of primary
shoots. The strategy employed lands one primer on the native
chloroplast genome adjacent to the point of integration and
the second primer on the aadA gene. This PCR product can
not be obtained in nuclear transgenic plants or spontaneous
mutants, thus both possibilities could be eliminated. It was
found that 90% of total shoots obtained were true chloroplast transformants. Confirmed transformants were subjected to a second round of spectinomycin selection to
achieve homoplasmy. They were rooted in the presence of
spectinomycin and then transferred to pots for further characterization. Southern blot analysis was performed to select
© Blackwell Publishing Ltd, Plant Biotechnology Journal (2003), 1, 71–79

accumulation was observed between plants transformed
with the two different vectors (Figure 3a): 0.02% vs. 7.2% tp
in pLDAsdHSA and pLDApsbAHSA transgenic lines, respectively. Chloroplast constructs with the SD sequence have
been demonstrated to direct CTB expression very efficiently (up to 4% of tsp; Daniell et al., 2001b). Similar constructs, but inserted in other areas of the plastid genome,
have also been successful (3–21% tsp; DeGray et al., 2001;
Kota et al., 1999), demonstrating that high protein expression levels can be achieved by using this construct in an
operon with a SD sequence. Thus, low levels of HSA expression in the pLDAsdHSA transgenic plants could not be due to
the effect of regulatory signals in the construct. Differences in
the amounts of HSA could be due to post-transcriptional,
translational or post-translational effects. To study differences
in HSA expression, transcript abundance was examined by
Northern blots, which were performed using the 3′psbA
region as the probe (Figure 2). The 5′psbA/HSA monocistron
transcript is much more abundant than the aadA/SD/HSA
dicistron, but such differences do not show a linear correlation with the 360-fold difference in HSA accumulation
between both transgenic lines. Such a lack of correlation
between transcript abundance and protein accumulation has
been reported from several laboratories when the psbA
5′UTR is used (Mayfield et al., 1995; Staub and Maliga, 1993,
1994), suggesting an important role of the psbA 5′UTR in
enhancement of translation. Eibl et al. (1999) also showed
that deletion of the terminal sequences of the psbA 5′UTR
decreased the ability of the UTR to enhance translation. Thus,
efficient translation in the pLDApsbAHSA transgenic line
might be an important factor in establishing high levels of
HSA accumulation.
There are several studies demonstrating that psbA 5′UTR
confers light-dependent translation not only to the psbA
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in the rate of transcription or transcript stability, but due to
the arrest of translation in the dark and the turnover of HSA
in the chloroplast.
Proteins from transformed plants were separated to study
the pattern of HSA accumulation within transgenic chloroplasts. Western blots confirmed differences in HSA quantities
among transgenic lines (Figure 3d). In pLDApsbAHSA transgenic lines, HSA is partially solubilized with the standard
buffer used for total protein extraction. This observation

Figure 2 Transcription patterns of transgenic plants. A Northern blot
analysis was performed with total RNA extracted from leaves of potted
plants. The 3′ of the psbA gene was used as probe. 1: untransformed
plant; 2: transformed with pLDAsdHSA; 3: transformed with
pLDApsbAHSA after illumination or 4: in the dark. Ethidium bromidestained rRNA was used to assess loading. Identified transcripts are
indicated to the right. A scheme of transcription patterns expected for
the different cassettes integrated into the chloroplast genome is shown
at the bottom of the figure. Horizontal arrows above genes show
anticipated transcripts. Arrows within boxes show the orientation of
genes within the chloroplast genome. Read through transcripts are not
shown in this figure. rRNA: ribosomal RNA.

gene (Zerges, 2000) but also to other heterologous proteins
(Eibl et al., 1999; Staub and Maliga, 1993, 1994). Expression
of HSA under the psbA 5′UTR control is therefore expected
to be light dependent. Changes in HSA accumulation after
different periods of illumination were monitored by ELISA
(Figure 3b). HSA quantity was observed to be maximum up
to 50 h of continuous illumination (11.1% of tp) in mature
leaves and a 2–4-fold decrease was observed after the 8 h
dark period. Such differences in HSA accumulation were so
pronounced that it was detected by staining gels with
Coomassie Brilliant Blue (Figure 3c). Staub and Maliga (1993,
1994) and Eibl et al. (1999) showed that although translation
is arrested in the dark, the 5′psbA/uidA mRNA turnover was
very low. This observation was confirmed for HSA by Northern blot analysis, which showed no major differences
between light and dark amount of 5′psbA/HSA transcripts
(Figure 2, lanes 3, 4). Therefore, differences in HSA accumulation between dark and light could not be due to differences

suggests formation of HSA aggregates inside transgenic
chloroplasts in the pLDApsbAHSA transformants. Electron
microscopy and immunogold labelling therefore were performed in transformed and untransformed plants to further
investigate this. As expected, electron micrographs of leaf
tissues showed formation of large aggregates or inclusion
bodies within transgenic chloroplasts of pLDApsbAHSA mature
transformed plants (Figure 4b–d). It is interesting to note that
chloroplasts containing inclusion bodies increased in size to accommodate large accumulation of HSA (compare Figures 4a,d).
However, the phenotype of these plants appeared normal
(Figure 5). The amount of HSA in pLDAsdHSA transgenic
chloroplasts was so low that it was not possible to detect
immunogold labelling above the background. No significant
changes in chloroplast size were observed in these plants.
Inclusion bodies have been often observed in the cytosol of
prokaryotes and eukaryotes when heterologous proteins are
overexpressed. The occurrence of this feature in the chloroplast was first reported by Ketchner et al. (1995). It is widely
known that protein aggregation into inclusion bodies mostly
involves intermolecular associations of partially folded intermediates (Mitraki and King, 1989). High protein concentrations usually lead to conditions that frequently exceed the
normal solubility limit. Even the most abundant protein in
photosynthetic cells, RuBisCO, forms inclusion bodies in
some cases. Many autotrophic bacteria and all cyanobacteria
package much of the RuBisCO into inclusion bodies actively
involved in the fixation of CO2, known as carboxysomes (Shively and English, 1991). Our hypothesis, based on the process
of formation of inclusion bodies, is that in contrast to pLDAsdHSA transgenic lines, HSA synthesized under the psbA
5′UTR forms large aggregates mainly due to the high local
concentration of the protein.
Formation of inclusion bodies is one of the strategies for
reducing the proteolysis of unstable recombinant proteins
(Enfors, 1992). The majority of recombinant proteins studied
have been shown to be highly resistant to proteolysis inside
inclusion bodies. Although there is protection from proteases
within inclusion bodies, some proteolysis can also take place
directly on the aggregated protein (Carrio et al., 1999). HSA
© Blackwell Publishing Ltd, Plant Biotechnology Journal (2003), 1, 71–79
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Figure 3 Analysis of HSA accumulation in transgenic chloroplasts. (a) ELISA of HSA accumulation in leaves of potted plants at different stages of
development. Samples were collected from untransformed plants or transformed with pLDAsdHSA or pLDApsbAHSA. Expression levels are indicated as
a percentage of total protein. (b) Study after different hours of illumination. Samples of leaves were collected from potted plants transformed with
pLDApsbAHSA after the 8-h dark period or at indicated hours in the light. (c) Coomassie stained gel to study HSA accumulation in tobacco leaves of
potted plants. Total protein extracts were loaded in the gel. 1: 500 ng pure HSA; 2: molecular weight marker; 3: untransformed plant; transformed with
4: pLDAsdHSA; 5: pLDApsbAHSA after 8 h of illumination; 6: pLDApsbAHSA after 8 h of darkness. Between 40 and 50 µg of plant protein were loaded
per well. The positions of HSA and RuBisCO large subunit (LSU) are marked. (d) Colorimetric immunoblot detection of tobacco protein extracts from
mature leaves in potted plants. Total protein extracts were loaded in the gel. 1: 40 ng pure HSA; 2: molecular weight marker; 3,5: untransformed plant
extract; 4: pLDAsdHSA plant extract; 6: pLDApsbAHSA plant extract. Between 40 and 50 µg of plant protein were loaded per well. kDa: kiloDalton; LSU:
RuBisCO large subunit.

also appears to be susceptible to some proteolytic degradation
within transgenic chloroplasts. However, the net balance
between synthesis and degradation is highly favourable,
especially after several hours of continuous illumination.
Properly folded HSA can be recovered from inclusion bodies after denaturation for complete solubilization and in vitro
refolding. Proper refolding of HSA from inclusion bodies is a
routine procedure that has been previously demonstrated in
several studies with E. coli (Latta et al. (1987) and Saccharomyces cerevisiae (Dodsworth et al., 1996; Quirk et al., 1989).
In these cases, human and recombinant refolded HSA were
compared and it was shown that the two proteins were structurally equivalent, demonstrating that HSA may be recovered
from inclusion bodies and properly folded. Following the
guidelines from these protocols, HSA was extracted from
transgenic chloroplasts. Figure 6a shows a silver stained
© Blackwell Publishing Ltd, Plant Biotechnology Journal (2003), 1, 71–79

SDS-PAGE gel in which HSA inclusion bodies could be separated from the soluble fraction (lane 3), where most of the
cellular proteins are found. After solubilization of inclusion
bodies and subsequent refolding, HSA could be completely
converted into monomeric forms (Figure 6a, lane 5; Figure
6b, lane 5). Our estimations of HSA yields at the end of the
protocol are about 20% of the initial quantities in leaves,
although the reported protocol has been performed at the
laboratory scale and may be further optimized for industrial
production. Expression of HSA in transgenic plants has been
estimated to be cost effective with levels of expression as low
as 0.1 mg HSA /g fresh weight (Farran et al., 2002). The
recoveries after solubilizing the inclusion bodies and refolding
the HSA are about 0.25 mg HSA /g fresh weight (excluding
soluble HSA in transgenic chloroplasts), which exceeds cost
effective estimations of pharmaceutical industries.
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Figure 4 Study of HSA accumulation into inclusion bodies. (a–d)
Electron micrographs of immunogold labelled tissues from
untransformed (a) and transformed mature leaves with the chloroplast
vector pLDApsbAHSA (b–d). Note presence of inclusion bodies (b–d)
marked with an arrow in (d). Scale bars indicate µm. Magnifications are
a × 10 000; b × 5000; c × 6300; d × 12 500.
Figure 6 HSA extraction from inclusion bodies. (a) Silver stained SDSPAGE gel showing 1: 500 ng pure HSA; 2: molecular weight marker;
soluble fraction obtained after centrifugation of pLDApsbAHSA
transformed plant extract (lane 3) or untransformed plant extract (lane 4);
5: HSA after solubilization from the pellet; 6: proteins from
untransformed plant, which followed the same process as the proteins of
lane 5. Amounts of protein loaded per well were 10 µg in lanes 3 and 4,
550 ng in lane 5 and 450 ng in lane 6. (b) Chemiluminiscent immunoblot
detection of protein extracts. 1: 40 ng pure HSA; 2: HSA from a plant
transformed with pLDApsbAHSA during the solubilization process,
showing mono, di and trimeric forms; 3: proteins from an untransformed
plant that followed the same process as the proteins for lane 2; 4: same
HSA from lane 2 but in a more advanced stage of solubilization; 5:
completely monomerized HSA after the end of the solubilization
treatment (the sample of this lane corresponds with lane 5 in (a)).

Figure 5 Plant T1 phenotypes. 1,2: untransformed plants; 3: plant
transformed with pLDAsdHSA; 4: plant transformed with
pLDApsbAHSA.

One of the primary goals of this study was to develop a
more efficient expression system for human serum albumin,
an important human therapeutic protein that is highly susceptible to degradation. Expression of HSA in mature plants
under the translational control of SD sequence resulted in
very low levels of HSA accumulation, probably due to exces-

sive proteolytic degradation and poor rates of translation.
However, when expressed under the control of psbA promoter and 5′UTR, up to a 500-fold increase in HSA accumulation was observed in mature plants compared to other
regulatory sequences tested. HSA was observed to form large
inclusion bodies, resulting even in a noticeable increase in the
size of transgenic chloroplasts and presumably offering protection to HSA from proteolytic degradation. Inclusion bodies
facilitated purification of HSA from other cellular proteins.
The HSA molecule has a chemical and structural function
rather than an enzymatic activity, therefore complex studies
are necessary to fully demonstrate the functionality of the
molecule (see Dodsworth et al., 1996; Ohtani et al., 1998;
Petersen et al., 2000; Tarelli et al., 1998; Watanabe et al.,
© Blackwell Publishing Ltd, Plant Biotechnology Journal (2003), 1, 71–79
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2001a,b). Such functional studies using in vitro refolded HSA
are in progress.

the oligolabelling procedure (Ready To Go, Amersham).
Probes were hybridized to the membranes following the
QUICK-HYB protocol (Duralon-UV, Stratagene).

Experimental procedures
Northern blot analysis
Chloroplast expression vectors
pLDAsdHSA was constructed by inserting the HSA 1.8 kb
EcoRI/NotI fragment into the multiple cloning site of the pLD
vector (Daniell et al., 1998; Daniell et al., 2001b; De Cosa
et al., 2001; Guda et al., 2000; Kota et al., 1999). This fragment contains the mature HSA coding sequence preceded by
a Shine-Dalgarno (GGAGG) and it has an ATG as the initiation
codon. These sequences were introduced by using the primer:
5′-GGAGGCAACCATGGATGCACACAAGAGTGAAGG-3′. For
the pLDApsbAHSA vector, the 204 bp sequence including the
promoter and the psbA 5′UTR, was amplified by PCR using
tobacco DNA as template. The following primers were used:
5′-CCGTCGACGTAGAGAAGTCCGTAT T-3′ and 5′-GCCCATGGTAAAATCTTGGT T TAT T TA-3′. The fusion with the HSA
gene was made at the NcoI site placed at the 3′ end of the
psbA 5′UTR and then inserted into the pLD vector as a EcoRI/
NotI fragment. Before proceeding with the bombardment,
vectors were tested by Western blot analysis in E. coli.

Total RNA was extracted from leaves of transformed and
untransformed plants (Rneasy Plant Kit, Qiagen). RNA 2.5 µg
was electrophoresed on 1.2% agarose/formaldehyde gels
and then transferred to nylon membranes (Stratagene). A
0.21 kb XbaI/PstI fragment of the 3′psbA gene was used as
probe and labelled with 32P-dCTP using the oligolabelling
procedure (Amersham).

HSA quantification
The ELISA Human Albumin Quantification Kit (Bethyl Laboratories) was used. Transformed and untransformed leaves
(100 mg) from potted plants grown under a 16 h photoperiod were ground in liquid nitrogen, resuspended in 700 µL of
50 mM NaOH and analysed following the manufacturer’s
protocol. Transgenic leaf extracts were diluted to fit in the
linear range of the provided HSA standard. Absorbance was
read at 450 nm. The DC protein assay (Bio-Rad) was used to
determine total solubilized protein.

Bombardment and regeneration
Sterile tobacco (cv. Petit Havana) leaves were bombarded
using the Bio-Rad PDS-1000/He biolistic device as described
previously (Daniell, 1997). Bombarded leaves were subjected
to two rounds of selection on the RMOP medium containing
500 µg/mL of spectinomycin to regenerate transformants
(Daniell, 1997). After regeneration, plants were rooted on
500 µg/mL of spectinomycin (Daniell et al., 2001b) and
transferred to pots in growth chambers. Photoperiod was
16 h light and 8 h dark.

PCR and Southern blot analysis
PCR was used to analyse integration of different cassettes in
the transformed plants as described (Daniell et al., 2001b,c;
De Cosa et al., 2001; Kota et al., 1999). For Southern blot
analysis, total DNA was extracted from leaves of transformed
and untransformed plants (Qiagen Dneasy Kit). Total DNA
(5 µg) was digested with BamHI, electrophoresed on 0.7%
agarose gels and transferred to nylon membranes (DuralonUV Stratagene). The template for probing flanking sequences
was a 0.81 kb BglII/BamHI fragment and for HSA a 0.75 kb
NcoI fragment. The probes were labelled with 32P-dCTP using
© Blackwell Publishing Ltd, Plant Biotechnology Journal (2003), 1, 71–79

SDS-PAGE and immunoblot analysis
Transformed and untransformed leaves (100 mg) were
ground in liquid nitrogen and resuspended in 200 µL of
protein extraction buffer (200 mM Tris-HCl pH 8.0, 100 mM
NaCl, 400 mM Sucrose, 14 mM βME, 0.05% Tween20, 0.1%
SDS, 10 mM EDTA, 2 mM PMSF). Leaf extracts were boiled
in sample buffer (Bio-Rad) and electrophoresed in a 10%
polyacrylamide gel. Separated proteins were stained with
Coomassie Brilliant Blue G-250 or transferred to a nitrocellulose membrane for immunoblotting. The primary antibody
(rabbit anti-HSA, Nordic Immunology) was used at 1 : 10 000
dilution, and the secondary antibody (alkaline phosphatase
conjugated mouse antirabbit, Sigma or goat antirabbit HRP
conjugated, Southern Biotechnology) at 1 : 15 000. Alkaline
phosphatase colour development reagents, BCIP/NBT, in AP
Color Development Buffer (Bio-Rad) or the ECL kit (Amersham) were used for detection.

Solubilization of inclusion bodies
Soluble proteins were removed with a first extraction in 0.2
M NaCl, 25 mM Tris-HCl pH 7.4, 2 mM PMSF and 0.1% Triton
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X-100. After centrifugation for 60 min at 20 000 g, the pellet
was solubilized for 16 h at 4 °C in 6 M Gu-HCl, 0.1 M βME and
0.25 mM Tris-HCl pH 7.4. After centrifugation for 60 min at
20 000 g, the supernatant was then slowly diluted 100-fold
in 100 mM NaCl, 50 mM Tris-HCl pH 8.5 and 1 mM EDTA for
24 h at 4 °C. Fractions were electrophoresed in a SDS-PAGE
10% gel and silver stained with Bio-Rad reagents and protocol.

Transmission electron microscopy and immunogold
labelling
Seedlings and mature leaves from untransformed and
transgenic plants were analysed. Fixation and immunogold
labelled electron microscopy were performed as described by
Vrekleij and Leunissen (1989). Sections were first blocked,
incubated for 1 h with a goat antihuman albumin polyclonal
antibody (Nordic Immunology; dilution range from 1 : 1000
to 1 : 10 000) and then incubated for 2 h with a rabbit antigoat IgG secondary antibody conjugate to 10 nM gold diluted
1 : 40 in blocking solution. Sections were examined in a Zeiss
EM 10 transmission electron microscope at 60 kV.
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